All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
VKTX / Viking Therapeutics, Inc.
|
|
|
|
|
|
|
|
AMED / Amedisys, Inc.
|
|
|
|
|
|
|
|
AGLE / Aeglea BioTherapeutics Inc
|
|
|
|
|
|
|
|
LOGC / ContextLogic Holdings Inc.
|
|
|
|
|
|
|
|
MIRM / Mirum Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
CRIS / Curis, Inc.
|
|
|
|
|
|
|
|
RDUS / Radius Recycling, Inc.
|
|
|
|
|
|
|
|
VREX / Varex Imaging Corporation
|
|
|
|
|
|
|
|
CNC / Centene Corporation
|
|
|
|
|
|
|
|
SVRA / Savara Inc.
|
|
|
|
|
|
|
|
KZR / Kezar Life Sciences, Inc.
|
|
|
|
|
|
|
|
OGN / Organon & Co.
|
|
|
|
|
|
|
|
HLF / Herbalife Ltd.
|
|
|
|
|
|
|
|
HZNP / Horizon Therapeutics Plc
|
|
|
|
|
|
|
|
SYRS / Syros Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
MCK / McKesson Corporation
|
|
|
|
|
|
|
|
AVAH / Aveanna Healthcare Holdings Inc.
|
|
|
|
|
|
|
|
CYCC / Cyclacel Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
AFMD / Affimed N.V.
|
|
|
|
|
|
|
|
PARDES BIOSCIENCES INC
/ (69945Q105) |
|
|
|
|
|
|
|
MEIP / MEI Pharma, Inc.
|
|
|
|
|
|
|
|
LPTX / Leap Therapeutics, Inc.
|
|
|
|
|
|
|
|
RIGL / Rigel Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
OYST / Oyster Point Pharma Inc
|
|
|
|
|
|
|
|
CAH / Cardinal Health, Inc.
|
|
|
|
|
|
|
|
ITGR / Integer Holdings Corporation
|
|
|
|
|
|
|
|
UHS / Universal Health Services, Inc.
|
|
|
|
|
|
|
|
SLRX / Salarius Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
VINC / Vincerx Pharma, Inc.
|
|
|
|
|
|
|
|
ISO / IsoPlexis Corp
|
|
|
|
|
|
|
|
NEOG / Neogen Corporation Put
|
|
|
|
|
|
|
|
IONS / Ionis Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
KOD / Kodiak Sciences Inc. Call
|
|
|
|
|
|
|
|
GLD / SPDR Gold Trust
|
|
|
|
|
|
|
|
BHC / Bausch Health Companies Inc. Put
|
|
|
|
|
|
|
|
VRTX / Vertex Pharmaceuticals Incorporated Put
|
|
|
|
|
|
|
|
DTIL / Precision BioSciences, Inc.
|
|
|
|
|
|
|
|
CRIS / Curis, Inc. Call
|
|
|
|
|
|
|
|
INBX / Inhibrx Biosciences, Inc.
|
|
|
|
|
|
|
|
ARNA / Arena Pharmaceuticals Inc
|
|
|
|
|
|
|
|
MEDP / Medpace Holdings, Inc.
|
|
|
|
|
|
|
|
VRTX / Vertex Pharmaceuticals Incorporated Call
|
|
|
|
|
|
|
|
MEOBF / Mesoblast Limited
|
|
|
|
|
|
|
|
CHAQ / Chardan Healthcare Acquisition 2 Corp
|
|
|
|
|
|
|
|
NARI / Inari Medical, Inc.
|
|
|
|
|
|
|
|
RCOR.WS / Renovacor, Inc. Warrants, enti Warrants, entitling the holder thereof to purchase one-half (1/2) of a share of common stock at a price of $11.50 per whole share
|
|
|
|
|
|
|
|
SRRA / Sierra Oncology Inc
|
|
|
|
|
|
|
|
AYLA / Ayala Pharmaceuticals Inc
|
|
|
|
|
|
|
|
NTUS / Natus Medical Inc
|
|
|
|
|
|
|
|
MBRX / Moleculin Biotech, Inc.
|
|
|
|
|
|
|
|
BLU / Bellus Health Inc Put
|
|
|
|
|
|
|
|
VAPO / Vapotherm, Inc.
|
|
|
|
|
|
|
|
ALBO / Albireo Pharma Inc
|
|
|
|
|
|
|
|
PNT / POINT Biopharma Global Inc.
|
|
|
|
|
|
|
|
NBSE / NeuBase Therapeutics, Inc.
|
|
|
|
|
|
|
|
ARDX / Ardelyx, Inc.
|
|
|
|
|
|
|
|
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
EUCRU / Eucrates Biomedical Acquisition Corp
|
|
|
|
|
|
|
|
NLTX / Neoleukin Therapeutics, Inc.
|
|
|
|
|
|
|
|
ABC / Amerisource Bergen Corp.
|
|
|
|
|
|
|
|
CNTB / Connect Biopharma Holdings Limited - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
MSAC / Medicus Sciences Acquisition Corp - Class A
|
|
|
|
|
|
|
|
HSAQ / Health Sciences Acquisitions Corp 2
|
|
|
|
|
|
|
|
XENE / Xenon Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
MRUS / Merus N.V.
|
|
|
|
|
|
|
|
ANIP / ANI Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
CBAY / CymaBay Therapeutics, Inc.
|
|
|
|
|
|
|
|
SNY / Sanofi - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
NKTR / Nektar Therapeutics Put
|
|
|
|
|
|
|
|
VNDA / Vanda Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
UTHR / United Therapeutics Corporation
|
|
|
|
|
|
|
|
CMAX / CareMax, Inc.
|
|
|
|
|
|
|
|
ASLN / ASLAN Pharmaceuticals Limited - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
ELEV / Elevation Oncology, Inc.
|
|
|
|
|
|
|
|
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
HUMAW / Humacyte, Inc. - Equity Warrant
|
|
|
|
|
|
|
|
FUSN / Fusion Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
NXTC / NextCure, Inc.
|
|
|
|
|
|
|
|
MRK / Merck & Co., Inc.
|
|
|
|
|
|
|
|
INGN / Inogen, Inc.
|
|
|
|
|
|
|
|
CMAXW / CareMax Inc - Warrants (08/06/2026)
|
|
|
|
|
|
|
|
NYXH / Nyxoah SA
|
|
|
|
|
|
|
|
TYRA / Tyra Biosciences, Inc.
|
|
|
|
|
|
|
|
CI / The Cigna Group
|
|
|
|
|
|
|
|
XFOR / X4 Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
LH / Labcorp Holdings Inc.
|
|
|
|
|
|
|
|